L eukemia inhibitory factor (LIF), a member of the interleukin (IL)-6 family of cytokines, is a growth and differentiation factor with pleiotropic activities. 1 LIF exists in 2 isoforms, as diffusible molecule (D-LIF) and as an extracellular matrix-bound isoform (M-LIF), with distinguishable functions. 2, 3 LIF binds to a receptor complex consisting of a LIF-specific receptor (LIFR) and the signal transducer gp130. 4, 5 This receptor complex mediates LIF signals via multiple signaling pathways following the Janus kinase/ signal transducers and activators of transcription (JAK/ STAT) and the mitogen-activated protein (MAP) kinase pathways. 6 Several other cytokines, including IL-6, oncostatin M, IL-11, ciliary neurotrophic factor, and cardiotrophin-1 share gp130 as a common signal-transducing molecule and therefore have some similar or redundant biological activities.
LIF acts as a growth factor in hematopoiesis and on bone and neuroectodermal tissue, and it mediates immunologic responses in acute inflammation. LIF also acts as an inhibitor of differentiation on embryonic stem (ES) cells and adipocytes (for review of functions, see Reference 1) . Notably, LIF seems to affect different developmental stages of endothelial cells, T cells, and different cells of the cardiovascular system in an opposite manner. [7] [8] [9] [10] Knockout of the LIF gene in mice demonstrated the importance of LIF for implantation of blastocysts 11 and stem cell renewal. 12 Overexpression of LIF in mice identified M-LIF as an inhibitor of mesodermal differentiation during gastrulation 3 and demonstrated different roles for M-LIF and D-LIF in murine development. Before gastrulation, LIF is downregulated to undetectable low levels, perhaps to allow commitment to the mesodermal lineage. During embryogenesis and in many adult tissues, LIF transcripts are found, if at all, in extremely low quantities. 13 Copy numbers of the transcript for M-LIF gain their highest level in the neonatal myocardium shortly before cardiomyocytes cease to divide. In primary cultures of embryonic or neonatal cardiomyocytes, LIF causes an antiapoptotic effect or hypertrophic response via the STAT3 pathway. 6, 14 These data support the hypothesis that LIF modulates cardiogenesis in a subtle, developmental stage-dependent, and perhaps opposite fashion. To study the function of LIF during cardiogenesis in vivo currently seems to be clearly beyond the state of the art, because D-LIF could not be detected in sera and heart tissue from healthy individuals, 15 nor is it feasible to detect M-LIF at physiological concentrations. Therefore, we exploited an in vitro model of cardiogenesis to investigate the significance of LIF in cardiomyogenesis. Many aspects of cardiogenesis can be studied in differentiating aggregates of ES cells, so-called embryoid bodies. 16 In embryoid bodies, all 3 germ layers and a variety of cell types form. Among them, cardiomyocytes become committed and differentiate in a manner closely recapitulating the developmental pattern of murine cardiogenesis. 17 In this study, we exploit embryoid bodies to study the role of D-LIF, and indirectly of M-LIF, in commitment, differentiation, and maintenance of the phenotype of cardiomyocytes. LIF affects cardiomyogenesis in stage-dependent and opposite ways. Paracrine D-LIF negatively affects commitment and, to a lesser extent, differentiation of cardiomyocytes. In contrast, in lifϪ/Ϫ embryoid bodies, cardiomyocyte differentiation is severely, although not completely, blocked and can be rescued by paracrine D-LIF. Either autocrine M-and D-LIF or subpicomolar concentrations of paracrine D-LIF are necessary and sufficient for the onset of differentiation in cardiomyocytes, whereas increasing concentrations of D-LIF attenuate ongoing differentiation of cardiomyocytes. Increased inhibition of timely commitment and differentiation of cardiomyocytes in lifrϪ/Ϫ embryoid bodies suggests that LIFR-independent signals contribute to the development of cardiomyocytes as well. Finally, paracrine and autocrine LIFs promote proliferation and longevity of fully differentiated cardiomyocytes.
Materials and Methods

Cell Lines and Differentiation of ES Cells
The ES cell line AB2.2, 18 passages 13 to 18, and SNL76/7 fibroblasts, 19 
Results
Commitment of Cardiomyocytes Is Inhibited by D-LIF
D-LIF is secreted at very low rates by STO fibroblasts and at significantly increased rates by SNL76/7 fibroblasts used as feeder cells to keep ES cells in an undifferentiated state. ES cells differentiate in embryoid bodies to beating cardiomyocytes, the subject of this study. In the course of refining this in vitro model of cardiomyogenesis, to address properly the influence of autocrine and paracrine factors on commitment and differentiation of cardiomyocytes, we observed that development of cardiomyocytes in embryoid bodies (1) was inversely correlated to the concentration of D-LIF in serum supplements and (2) was significantly hampered in the presence of SNL76/7 fibroblasts. At the time when mesodermal precursors of cardiomyocytes form in embryoid bodies, presence of SNL76/7 fibroblasts significantly delayed commitment of cardiomyocytes ( Figure 1A ). The number of embryoid bodies with beating cardiomyocytes was dosedependently reduced as compared with embryoid bodies developed in the presence of STO fibroblasts and in the absence of any feeder cells, respectively ( Figure 1B ). Addition of LIF-neutralizing antibodies during formation of the precardiac mesoderm significantly increased commitment of cardiomyocytes, in the absence of fibroblasts and in the presence of both STO and SNL76/7 fibroblasts ( Figure 1C ). The effect of LIF-neutralizing antibodies was inversely correlated to the expression level of LIF.
To demonstrate that the effects observed in the presence of SNL76/7 feeder cells were solely due to D-LIF, we aggregated ES cells in the presence of increasing concentrations of recombinant D-LIF for 4 days. Commitment of cardiomyocytes was attenuated and delayed by D-LIF in a dosedependent manner ( Figure 2A ). As little as 1 pmol/L D-LIF attenuated commitment of cardiomyocytes down to 40% of the control, and 10 pmol/L reduced the percentage of embryoid bodies with developing cardiomyocytes to Ͻ10% ( Figure  2B ). As determined by visual inspection of embryoid bodies, between 1 and 10 pmol/L D-LIF mesoderm and endoderm formed. Inhibition of development was apparently restricted to the cardiogenic lineage, because other cell types such as fibroblasts, endothelial and epithelial cells, etc, developed at rates indistinguishable from that of parallel control experiments.
To exclude that effects observed were not solely due to D-LIF, but to expression of an unknown fibroblast-specific factor, we generated embryoid bodies in the presence of SNL76/7, wild-type, and lifϪ/Ϫ fibroblasts. Aggregation of ES cells in the presence of increasing numbers of SNL76/7 fibroblasts severely hampered commitment of cardiomyocytes in a dose-dependent manner, whereas development of cardiomyocytes in the presence of lifϪ/Ϫ fibroblasts and wild-type fibroblasts, respectively, was not significantly altered ( Figure 2C ). Weak reduction of the number of cardiomyocytes with increasing numbers of fibroblasts was due to exhaustion of nutrition factors in the drop cultures. These data prove that under our experimental conditions, cardiomyogenesis was not significantly inhibited by factors other than D-LIF.
Cardiomyogenesis in lifϪ/Ϫ ES cell 20 -derived embryoid bodies was hampered and reduced to Ϸ20% of the rate in wild-type embryoid bodies. Addition of 10 pmol/L D-LIF could partially rescue differentiation of lifϪ/Ϫ cardiomyocytes when added from day 4 to day 11 ( Figure 2D ). In contrast, a continuous supply of 10 pmol/L D-LIF after day 4 could not rescue the suppressive effect exerted between days 0 and 4. Consequently, D-LIF suppresses commitment of cardiomyocytes between days 0 and 4 in embryoid bodies, and neither autocrine M-or D-LIF nor paracrine D-LIF is required for proper commitment of cardiomyocytes.
Differentiation of Cardiomyocytes Is Induced and Then Attenuated by LIF
The above findings indicated that initiation of cardiogenesis in the primitive mesoderm takes place in the absence of LIF only. To assess the influence of LIF on differentiation of committed cardiomyocytes, we plated embryoid bodies at day 4 after aggregation, first in the presence of STO, SNL76/7, wild-type, and lifϪ/Ϫ fibroblasts, respectively, and second, in the presence of D-LIF and neutralizing quantities of anti-LIF antibodies, respectively. With proceeding differentiation, reduced numbers of cardiomyocytes developed in the presence of SNL76/7 fibroblasts and D-LIF, respectively ( Figure 3A ), whereas differentiation of cardiomyocytes was not significantly influenced by either STO fibroblasts or lifϪ/Ϫ fibroblasts ( Figure 3B ). In the presence of antibodies neutralizing LIF, differentiation of cardiomyocytes was accelerated, and percentage of embryoid bodies developing beating foci of cardiomyocytes was significantly increased ( Figures 3A and 3B) . These results together demonstrate that subpicomolar concentrations of D-LIF attenuate differentiation of cardiomyocytes in embryoid bodies.
Differentiation but not commitment of cardiomyocytes was severely hampered and delayed in embryoid bodies generated from lifϪ/Ϫ ES cells. This phenotype could be partially rescued by as little as 1 pmol/L D-LIF ( Figure 4A ). This demonstrates that autocrine LIF, which includes M-LIF in murine cells, is essential for initiation of differentiation of cardiomyocytes in embryoid bodies. With increasing concentrations of D-LIF, differentiation of cardiomyocytes in lifϪ/Ϫ embryoid bodies was attenuated in a dose-dependent manner ( Figure 4B ). These data demonstrate that (1) commitment of cardiomyocytes takes place in the absence of autocrine Mand D-LIF; (2) D-LIF at very low concentrations of Ͻ1 pmol/L is necessary and sufficient to induce differentiation of cardiomyocytes in lifϪ/Ϫ embryoid bodies; and (3) after the inductive event, D-LIF attenuates differentiation of cardiomyocytes in a dose-dependent manner.
In the absence of LIFR in lifϪ/Ϫ ES cell 21 -derived embryoid bodies, cardiomyogenesis was hampered and delayed to way below the level observed in lifϪ/Ϫ embryoid Figure 1 . Commitment of cardiomyocytes is hampered by SNL76/7 fibroblasts expressing LIF. A, Commitment of cardiomyocytes in embryoid bodies generated by aggregation of ES cells in the absence of fibroblasts (ࡗ) and in the presence of STO fibroblasts (F) and SNL76/7 fibroblasts (E), respectively. Each data point represents mean (from 1 representative experiment of 3) of a given dayϮ1 day to eliminate periodic waves due to change of medium every 3 days. B, Embryoid bodies were generated in the absence of fibroblasts (control) and in the presence of 60 STO (STO), 60 SNL76/7 (60), and 100 SNL76/7 (100) fibroblasts per drop and 400 ES cells. C, Embryoid bodies were generated in the absence of any fibroblasts and in the presence of 60 STO and 60 SNL cells, respectively. Half of these plates were incubated with neutralizing anti-LIF antibodies during aggregation (ϩAB). B and C, Means given in arbitrary units were calculated from data sampled from day 6 to day 11 after aggregation, from 3 independent experiments. Numbers of embryoid bodies checked were as follows: for B, STO, nϭ774; SNL76/7, nϭ688; 60 SNL76/7, nϭ285; and 100 SNL76/7, nϭ1032; for C, control/ϩAB, nϭ225; STO/ϩAB, nϭ234; and SNL/ϩAB, nϭ246. Error bars indicate SD x n-1 .
bodies; however, it was not completely blocked ( Figure 4C ). lifrϩ/Ϫ embryoid bodies exhibited an intermediate phenotype. This result demonstrates indirectly that (1) other IL-6 family members signaling via LIFR also contribute to commitment and differentiation of cardiomyocytes and (2) some cardiomyocytes become committed and differentiate by a LIFR-independent pathway. Taken together, differentiation of cardiomyocytes is dependent on concentrations of Ͻ1 pmol/L of paracrine D-LIF or autocrine M-LIF and D-LIF, and higher levels of D-LIF attenuate differentiation of cardiomyocytes.
LIF Promotes Proliferation and Longevity of Differentiated Cardiomyocytes
Paracrine production of LIF during in vitro differentiation of ES cells has been shown to play a major role in stem cell renewal, 20 and nanomolar concentrations of D-LIF exert a hypertrophic and antiapoptotic stimulus on neonatal cardiomyocytes. 6, 14 Hence, we ask whether paracrine or autocrine LIF contributes to proliferation and maintenance of the phenotype of cardiomyocytes in embryoid bodies. In previous experiments, we noticed that presence of SNL76/7 fibroblasts increased longevity of differentiated cardiomyocytes in embryoid bodies (data not shown). To demonstrate that increased longevity of cardiomyocytes was caused at least in part by LIF overexpressed by SNL76/7 fibroblasts, we added increasing concentrations of D-LIF, and LIF-neutralizing antibodies, respectively, starting at day 11, when cardiomyocytes were fully differentiated. D-LIF increased longevity of cardiomyocytes by 15% ( Figure 5A ). In addition, a concentration-dependent and short-lasting hypertrophic response was observed. D-LIF acts as a proliferative stimulus on fully differentiated cardiomyocytes in a dose-dependent manner ( Figure 5B ). LIF-neutralizing antibodies blocked the antiapoptotic effect observed in the presence of D-LIF and SNL76/7 fibroblasts, respectively, and reduced longevity of cardiomyocytes well below the value observed in the absence of any fibroblasts ( Figure 5C ). This demonstrates that autocrine secretion of LIF by embryoid bodies contributes to the longevity of cardiomyocytes. In contrast to the negative effects of LIF on commitment and differentiation of cardiomyocytes, addition of D-LIF induces a short proliferative burst in differentiated cardiomyocytes, and both paracrine and autocrine LIF increase the longevity of differentiated cardiomyocytes.
Discussion
In murine embryos, mesoderm emerges at the midstreak stage between 6.5 and 7.0 days postcoitum. Commitment of meso- 
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dermal cells to the cardiogenic lineage takes place during anterolateral migration at late primitive streak stage. Precardiomyocytes can be identified in the horseshoe-shaped splanchnic mesoderm 7.75 days postcoitum. 26 In embryoid bodies, these developmental stages take place between 2 and 5 days after aggregation of ES cells. 27 Between days 6 and 7 after aggregation, cardiomyocytes start to beat rhythmically. 17 During murine embryogenesis, maternal LIF is of cardinal importance for successful implantation of blastocysts at Ϸ4.5 days postcoitum. 11 Then LIF is downregulated in the embryo proper to facilitate gastrulation and development of mesodermal cells, 3 and transcripts are barely detectable. 13, 28 Transcripts of M-LIF gain abundance after birth, when cardiomyocytes are fully differentiated; nevertheless, they remain in the cell cycle for another dozen days. In embryoid bodies, downregulation of LIF during gastrulation was mimicked by aggregating ES cells in medium supplemented with serum containing very low levels of LIF. By this measure, we were able to recapitulate many aspects of cardiomyogenesis in vitro and to address the opposite effects of LIF during commitment, differentiation, and maintenance of cardiomyocytes in embryoid bodies.
In the presence of D-LIF from the very beginning of ES cell differentiation, we observed a dose-dependent inhibition of mesoderm formation similar to effects observed with P19 embryonic carcinoma cells. 29 This suggests that D-LIF has to be downregulated before gastrulation to levels well below 1 pmol/L to allow mesoderm to form and to progress along the cardiogenic lineage. D-LIF at 1 nmol/L inhibited pathways leading to endodermal cells distal to the Reichert's membrane so that embryoid bodies no longer were able to adhere to the culture dishes. To test whether formation of mesoderm per se was inhibited or only consecutive differentiation of mesodermal cells along the cardiogenic lineage was attenuated in embryoid bodies, we added D-LIF after mesodermal precursors had become committed to the cardiogenic lineage after day 4. Any concentration tested starting from as little as 10 fmol/L LIF attenuated differentiation of cardiomyocytes. Released block of differentiation by neutralizing anti-LIF antibodies corroborated the negative effect of D-LIF on cardiomyocyte development. However, in the complete absence of LIF in lifϪ/Ϫ embryoid bodies, timely differentiation of cardiomyocytes was hampered and delayed. This suggests, first, that at least low levels of autocrine D-and/or M-LIF are necessary for differentiation of cardiomyocytes, and second, that LIF mediates a short-lasting inductive effect triggering cardiomyocyte differentiation. Most recently, a similar role has been demonstrated for LIF in the mesenchymal-to-epithelial conversion in the metanephron. 30 The dominant-negative effect of LIF on commitment and differentiation may contribute to the proper development of the embryonic heart and to the modulation of pathophysiological processes in myocardial disease.
In lifϪ/Ϫ embryoid bodies, lack of autocrine M-and D-LIF hampered and delayed cardiomyogenesis significantly; however, at times when wild-type cardiomyocytes usually ceased to divide, a second population of cardiomyocytes stepped into existence. From this we may speculate that at least 2 populations of cardiomyocytes form in embryoid bodies. We observed a LIF-sensitive lineage of cardiomyocytes concomitantly developing at the time when early heart development takes place in the murine embryo and a second, perhaps LIF-independent, lineage developing around day 20 after ES cell aggregation. The later one was observed in lifϪ/Ϫ and lifrϪ/Ϫ embryoid bodies and in wild-type embryoid bodies, in which development of the first lineage was blocked by paracrine D-LIF (A. Bader and G. Weitzer, unpublished results, 1999) . Cardiomyocytes formed later on during development may be triggered to differentiate by a different signal molecule in the absence of autocrine LIF. A good candidate in lifϪ/Ϫ embryoid bodies is cardiotrophin-1, which originally has been isolated from embryoid bodies. 31 A second LIF-independent pathway triggering cardiomyogenesis is suggested by the incomplete block of commitment and differentiation of cardiomyocytes in lifrϪ/Ϫ embryoid bodies. This late onset of cardiomyocyte development may be caused by a factor secreted from embryoid bodies at later stages of development, which obviously does not belong to the LIFR ligand family. A candidate factor may be the "ES cell renewal factor" isolated from lifϪ/Ϫ endodermal cells. 20 Once cardiomyocytes were fully developed, D-LIF exerted an opposite function, as observed during the development of cardiomyocytes. With increasing concentrations of LIF, longevity of cardiomyocytes was significantly increased by suppressing apoptosis, as has been demonstrated previously for primary cultures of cardiomyocytes. 14 In addition, a weak and short-lasting hypertrophic response in cardiomyocytes was observed. We think that LIF may delay the irreversible exit of fully differentiated cardiomyocytes from the cell cycle in the neonatal heart, because in vivo M-LIF is expressed concomitantly in the murine myocardium. 13 The physiological relevance of the dominant-negative effect of LIF during cardiogenic commitment and differentiation may be illustrated by the fact that this process in embryoid bodies correlates with inhibition of mesoderm formation in embryos overexpressing M-LIF. 3 The temporally increased proliferation and longevity of fully differentiated cardiomyocytes in embryoid bodies correlate with the regain of detectable levels of M-LIF transcripts in the neonatal heart. 13 Opposite functions of LIF, as demonstrated for cardiomyocytes, have also been reported for various phases of T-cell development, 9 suggesting that paracrine and autocrine LIF-mediated signal transduction may switch from positive to negative regulation, and vice versa, depending on developmental and physiological stages of a particular cell type. LIF may not only share functional redundancy with other IL-6 family members because of the shared usage of LIFR and gp130, but for the same reason, and provided that different binding specificity exists, LIF may act as a competitive inhibitor of factors such as cardiotrophin-1. 32 This may explain how LIF can act both as an activator and an inhibitor with subtle regulatory roles in developing cardiomyocytes. The mutual roles of LIF may be additionally tuned by LIFR, expressed as soluble and high-affinity, membrane-bound, and gp130-associated isoforms. 33 Altered ligand binding affinity and different expression patterns of these receptors may modulate the functions of LIF or the susceptibility of cells to LIF as well. The putative roles of these LIFR isoforms in cardiomyocytes remain to be studied. LIF seems to be dispensable for cardiogenesis in mice 11 ; however, we were able to demonstrate that subpicomolar concentrations of LIF modulate the cardiogenic pathway in a subtle and disparate fashion, and that a LIF-null allele severely hampers cardiomyogenesis in embryoid bodies. In knockout mice, LIF is most likely substituted by other members of the IL-6 family, because knockout of gp130 indeed led to embryonic lethal defects in the ventricular myocardium, 34 and knockout of the lifr gene led to pleiotropic effects causing perinatal death. 35 This suggests that LIF contributes, together with a plethora of other factors, to the proper formation and maintenance of the vertebrate heart.
Much is currently known regarding the development of the heart, 36 but little is understood regarding the maintenance of the differentiated state of cardiomyocytes. Several lines of evidence suggest that differentiation requires continuous regulation by transcription factors and growth factors. A hierarchy of regulators leads to and defines each developmental stage of cardiogenesis. Once cardiomyocytes are fully differentiated, they have to perform their vitally important function throughout the life of an organism. To maintain that stable state, feedback mechanisms may be required to circumvent the regulatory hierarchy and sustain a threshold level of critical regulators of the cardiac phenotype. In the case of myoblasts, such a mechanism may be provided by the myoD family of myogenic transcription factors and by transcription of the 3Ј-untranslated regions of structural genes. 37 A role in maintenance of the cardiac phenotype has been demonstrated for the muscle-specific intermediate filament protein desmin 38, 39 ; however, little else is known about regulators of the fully differentiated state of cardiomyocytes. We suggest that M-and D-LIF exert such a maintaining role at very low concentrations, presumably together with a plethora of other factors, owing to the shared usage of gp130. The presence of very low levels of both M-and D-LIF in the myocardium seems to modulate cardiogenesis in a subtle, time-sensitive, and opposite fashion and to control proliferation and maintenance of the fully differentiated state of cardiomyocytes.
